3 things every investor must know before buying Newcrest Mining Limited

Does Newcrest Mining Limited (ASX: NCM) have what it takes to beat the market?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

As volatility starts creeping back into world share markets now is the time to consider adding exposure to gold to your portfolio.

Newcrest Mining Limited (ASX: NCM) is the largest ASX listed gold miner and a natural starting point. However not all gold miners are created equal, so here are three things every investor must know about Newcrest Mining before buying:

1. Cost and production

The good news for investors is that for the most recent June production quarter, Newcrest Mining ranked as the lowest cost gold producer of seven major ASX listed companies. Newcrest had an average All-In Sustaining Cost (AISC) per ounce of just $913 for the quarter, beating out other gold miners (in this case Silver Lake Resources Limited (ASX: SLR)) by as much as $484 per ounce.

Newcrest is helped by its significant economies of scale. The company produces over half-a-million ounces of gold per quarter and this is a competitive advantage which is likely to continue driving low costs in the years ahead.

2. Outlook

Newcrest expects to produce up to 2.4 million ounces of gold in FY15 and forecasts positive cash flows at a gold price of just US$1,250 per ounce. The low hurdle rate is a good sign for investors that Newcrest's operational efficiency can continue.

3. Legacy problems

Despite Newcrest's positive operations, legacy problems still hang over the company.

The most pressing is a class-action lawsuit against the company by listed law firm Slater & Gordon Limited (ASX: SGH) on behalf of shareholders. The suit relates to disclosure of Newcrest's ASX release of 7 June 2013 which resulted in the company settling with the Australian Securities and Investments Commission (ASIC) for $1.2 million.

Newcrest also has a history of significant asset write downs which could come to $820 million in FY15. This would be on top of $6.2 billion written down in FY13 and up to $2.5 billion for FY14.

To give this context, the total of these three write downs is more that the company's current market capitalisation.

Motley Fool contributor Regan Pearson does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »